Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies 2020 | 4-year Horizon 2020 ITN-Marie Curie training network

Troels Jordansen • 1 Sep 2020
Advanced Therapies 2020
General

Troels Jordansen, of Glycostem Therapeutics, Oss, The Netherlands, discusses the 4-year Horizon 2020 ITN-Marie Curie training programme aiming to develop novel methods to manufacture tumor reactive NK cells.This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Troels Jordansen

1:18
World's first off-the-shelf NK cellular immunotherapy
Troels Jordansen • 1 Sep 2020

Related Videos

0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
1:26
Rapid CAR-T manufacturing and challenges in this space
Nina Worel • 9 Feb 2023
1:13
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells
Yasmin Nouri • 9 Feb 2023
2:08
Streamlining cell therapy manufacturing with CliniMACS Prodigy
Saskia Rösch • 6 Apr 2022
The content of VJRegenMed is intended for healthcare professionals